TSHA
NASDAQ · Biotechnology
Taysha Gene Therapies Inc
$4.43
+0.30 (+7.26%)
Open$4.24
Previous Close$4.13
Day High$4.53
Day Low$4.20
52W High$6.02
52W Low$1.05
Volume—
Avg Volume2.41M
Market Cap1.23B
P/E Ratio—
EPS$-0.33
SectorBiotechnology
Analyst Ratings
Strong Buy
20 analysts
Price Target
+1,273.8% upside
Current
$4.43
$4.43
Target
$60.86
$60.86
$45.99
$60.86 avg
$68.15
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 9.27M | 249.41M | 242.81M |
| Net Income | -99,337,915 | 43.60M | 41.01M |
| Profit Margin | -1,071.6% | 17.5% | 16.9% |
| EBITDA | -105,570,882 | 65.17M | 60.77M |
| Free Cash Flow | — | 41.80M | 46.40M |
| Rev Growth | — | +22.8% | -6.9% |
| Debt/Equity | 0.63 | 0.76 | 0.58 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $207.18 | +0.96% | 166.6 | 397.77B |
| AMGN | Amgen Inc | $353.93 | +1.58% | 24.4 | 188.06B |
| GILD | Gilead Sciences Inc | $138.26 | +0.11% | 20.0 | 170.34B |
| VRTX | Vertex Pharmaceuticals Inc | $454.97 | +1.42% | 29.2 | 115.53B |
| REGN | Regeneron Pharmaceuticals | $749.47 | +1.05% | 17.9 | 80.50B |
| ALNY | Alnylam Pharmaceuticals Inc | $328.70 | +6.70% | 139.7 | 43.84B |